News
U.S. approves first-ever biannual shot to prevent HIV, but getting it might be hard
WASHINGTON — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that could protect millions – although it’s unclear how many in the U.S. and abroad will get access to the powerful new option.
The National Institutes of Health office responsible for issuing federal guidelines related to treatment of HIV and AIDS ...
HIV targets the white blood cells and weakens the immune system. This would make the person prone to diseases like tuberculosis, infections and some cancers ...
HIV and global health activists say the deployment of Gilead’s twice-a-year HIV prevention shot is the world’s best chance to ...
The drug, lamivudine, appears to improve vision that’s being threatened by diabetic macular edema (DME), an eye condition in ...
The approach employed by the research team could be used against other diseases—including COVID-19 and influenza.
HIV is surging among adults over 50 in sub-Saharan Africa, yet prevention and treatment campaigns still focus mainly on the ...
In a song out during Pride month and ahead of HIV testing day on June 27, a Nashville country singer discusses his own ...
Over 1,200 individuals gathered at Kapiʻolani Park on June 21 to participate in the 34th annual Walk for Life, Honolulu’s ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback